Ticlopidine
| Price | $1 |
| Package | 1KG |
| Min. Order: | 1KG |
| Supply Ability: | 20tons |
| Update Time: | 2020-01-09 |
Product Details
| Product Name: Ticlopidine | CAS No.: 55142-85-3 |
| Min. Order: 1KG | Purity: 85.0-99.8% |
| Supply Ability: 20tons | Release date: 2020/01/09 |
| No.: Lisa 504 |
Lisa@coreychem.com
▼
▲
Product Name:
Ticlopidine
Synonyms:
2-c)pyridine,4,5,6,7-tetrahydro-5-((2-chlorophenyl)methyl)-thieno(;5-((2-Chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine;5-(O-Chlorobenzyl)-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine;PCR 5332;pcr5332;Thieno(3,2-c)pyridine, 4,5,6,7-tetrahydro-5-((2-chlorophenyl)methyl)-;TICIOPIDINE;Ticlopidine (base and/or unspecified salts)
CAS:
55142-85-3
MF:
C14H14ClNS
MW:
263.79
EINECS:
259-498-5
Product Categories:
Mol File:
55142-85-3.mol
▼
▲
Ticlopidine Chemical Properties
▼
▲
Melting point
210-212 °C
Boiling point
117-120 °C(Press: 0.5 Torr)
density
1.273±0.06 g/cm3(Predicted)
pka
7.10±0.20(Predicted)
CAS DataBase Reference
55142-85-3(CAS DataBase Reference)
NIST Chemistry Reference
Thieno[3,2-c]pyridine, 5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydro-(55142-85-3)
EPA Substance Registry System
Thieno[3,2-c]pyridine, 5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydro- (55142-85-3)
Company Profile Introduction
Established in 2014,Career Henan Chemical Co. is a manufacturerspecializing in the sale of fine chemicals.
Mainly deals in the sales of:
Pharmaceutical intermediates
OLED intermediates：
Pharmaceutical intermediates;
OLED intermediates;
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $1.10/1g |
VIP4Y
|
Dideu Industries Group Limited
|
2021-08-04 | |
| $6.00/1KG |
VIP1Y
|
Henan Fengda Chemical Co., Ltd
|
2024-01-24 | |
| $0.00/25KG |
VIP4Y
|
Hebei Mojin Biotechnology Co., Ltd
|
2023-09-06 | |
| $0.00/25kg |
Zhejiang Hengkang Pharmaceutical Co., Ltd.
|
2022-09-02 |
China- Since: 2014-12-17
- Address: Room 702, Floor 7, Building 10, National University Science Park, High-Tech Zone, Zhengzhou City, H
INQUIRY